ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma

Hu, Zhicheng; Qu, Shanqiang*南方医科大学; 中山大学; 1
Frontiers in Immunology2021-6-29DOI: 10.3389/fimmu.2021.683572
15被引5阅读
引用收藏
分享

摘要

Background Immunotherapy is an effective therapeutic approach for multiple human cancer types. However, the correlations between EVA1C and patients' prognosis as well as immune infiltration remain obscure. Herein, we employed transcriptomic and clinical data extracted from two independent databases to systematically investigate the role of EVA1C in the oncological context. Methods The differential expression of EVA1C was analyzed via TCGA and Oncomine databases. We evaluated the influence of EVA1C on clinical prognosis using Kaplan-Meier plotter. We then used the expression profiler to calculate stromal score, immune score, and ESTIMATE score based on the ESTIMATE algorithm. The abundance of infiltrating immune cells was calculated via TIMER. The correlations between EVA1C expression and immune infiltration levels were analyzed in two independent cohorts. Results In patients with World Health Organization (WHO) grade II/III glioma, high EVA1C expression was associated with malignant clinicopathological features and poor overall survival in both cohorts. EVA1C expression was positively associated with immune infiltration levels of B cell, CD4+ T cell, neutrophil, macrophage, and dendritic cells (DCs). Besides, EVA1C expression strongly correlated with diverse immune marker sets. And the predictive power of EVA1C was better than that of other indicators in predicting high immune infiltration levels in glioma. Conclusions For the first time, we identified the overexpression of EVA1C in glioma, which was tightly correlated with the high infiltration levels of multiple immune cells as well as poor prognosis. Meanwhile, EVA1C might be a potential biomarker for predicting high immune infiltration in WHO grade II/III gliomas.

学科与关键词

关键词
EVA1Cimmune infiltrationbiomarkergliomamicroenvironment
相关
加载中…
  • EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
    Qu, Shanqiang*; Liu, Jin; Wang, Huafu*Frontiers in Immunology, 2021, 12: 648416.被引 15
  • ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy
    Cheng, Xingbo; Liu, Zhendong; Liang, Wenjia; Zhu, Qingyun; Wang, Chao; Wang, Hongbo; Zhang, Jiangfen; Li, Pengxu; Gao, Yanzheng*International Journal of Biochemistry and Cell Biology, 2023, 158: 106409.被引 3
  • Identification of COL1A1 associated with immune infiltration in brain lower grade glioma
    Ren, Junyu; Da, Junlong; Hu, Narisu*PLoS One, 2022, 17(7).被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-06-29
卷期
第 12 卷
页码
683572
DOI
10.3389/fimmu.2021.683572
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE

作者

  • H

    Hu, Zhicheng (第一作者)

    1 · sun yat sen univ

  • Q

    Qu, Shanqiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417